Archive: 19/10/2015

Biosimilars—clinical perspectives in rheumatology

Universitätsmedizin Berlin and the University of Massachusetts Medical School have been analyzing clinical data on biosimilars that have already been approved for use. The term 'biosimilars' refers to drugs that mimic the ...

page 7 from 11